Drug Development Research
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.2 | Q2 | 71.6% | 0.765 | Q2 | 75.8% |
| 2024 | 4.2 | Q1 | 79.0% | 0.756 | Q2 | 76.1% |
| 2023 | 3.5 | Q2 | 72.6% | 0.672 | Q2 | 74.5% |
| 2022 | 3.8 | Q2 | 69.1% | 0.651 | Q2 | 74.5% |
| 2021 | 5.0 | Q2 | 78.4% | 0.552 | Q3 | 70.1% |
| 2020 | — | — | 0.582 | Q2 | 70.9% | |
| 2019 | — | — | 0.483 | Q3 | 66.5% | |
| 2018 | — | — | 0.779 | Q2 | 77.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1098-2299
ISSN
0272-4391
region
Northern America
coverage
1981-2026